Concord Wealth Partners Illumina, Inc. Transaction History

Concord Wealth Partners

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$127.73 - $147.2 $0 - $0	0 Closed	0 $0
Q4 2023 Apr 30, 2024	SELL	$92.79 - $142.53 $1,020 - $1,567	-11 Closed	0 $0
Q4 2023 Feb 05, 2024	SELL	$92.79 - $142.53 $1,020 - $1,567	-11 Closed	0 $0
Q3 2023 Apr 30, 2024	BUY	$128.91 - $192.44 $1,418 - $2,116	11 New	11 $1,000
Q4 2022 Jan 27, 2023	BUY	$187.24 - $242.74 $2,059 - $2,670	11 New	11 $2,000
Q2 2022 Aug 04, 2022	SELL	$181.58 - $368.0 $17,613 - $35,696	-97 Reduced 73.48%	35 $6,000
Q1 2022 Apr 20, 2022	BUY	$303.87 - $423.8 $4,861 - $6,780	16 Added 13.79%	132 $46,000
Q4 2021 Jan 21, 2022	BUY	$347.28 - $421.83 $33,686 - $40,917	97 Added 510.53%	116 $44,000
Q3 2021 Nov 09, 2021	SELL	$405.61 - $524.84 $23,119 - $29,915	-57 Reduced 75.0%	19 $8,000
Q2 2021 Jul 29, 2021	BUY	$372.84 - $481.5 $10,812 - $13,963	29 Added 61.7%	76 $36,000
Q1 2021 May 13, 2021	BUY	$361.28 - $504.76 $16,980 - $23,723	47 New	47 $18,000

933

140M

1.24M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $16.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.